Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks. As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property. Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews. Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues. The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding. Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC). The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review. Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review.

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Custom text		Organization Sort descending
Nov 14 2020	China Releases Draft Revised Patent Examination Guidelines for Comment	Schwegman, Lundberg & Woessner, P.A.
Dec 16 2020	The China National Intellectual Property Administration Releases Guiding Cases for Administrative Enforcement of Intellectual Property Rights	Schwegman, Lundberg & Woessner, P.A.
Sep 30 2014	PTAB Joinder Practice Update: Board Interprets 35 U.S.C. § 315(c) to Require Party Joinder	Schwegman, Lundberg & Woessner, P.A.
Jan 20 2021	Top Patentees in China for 2020	Schwegman, Lundberg & Woessner, P.A.
Oct 17 2014	Target Corp. Requests Rehearing of Denied Inter Partes Review by Expanded Patent Trial and Appeal Board Panel	Schwegman, Lundberg & Woessner, P.A.
Feb 12 2021	China Issues Draft “Measures Regarding the Regulation of Patent Applications” to Crack Down on ‘Abnormal’ Patent Applications	Schwegman, Lundberg & Woessner, P.A.
Oct 21 2014	Biotechnology Industry Organization (BIO) Provides Supplemental Comments on PTO s.101 Guidelines	Schwegman, Lundberg & Woessner, P.A.
Apr 21 2017	Novartis AG, LTS et al. v. Noven Pharmaceuticals, Inc. – Prior Judicial Opinions Don’t Bind the PTAB	Schwegman, Lundberg & Woessner, P.A.
Mar 2 2021	China Remains Top Patent Cooperation Treaty Application Filer in 2020	Schwegman, Lundberg & Woessner, P.A.
Apr 9 2021	Neapco’s Brief in Opposition to AA’s Petition for Cert.	Schwegman, Lundberg & Woessner, P.A.
Jan 2 2015	Book Review: Post-Grant Proceedings Before the Patent Trial and Appeal Board	Schwegman, Lundberg & Woessner, P.A.
Jun 16 2021	Beijing Intellectual Property Court Affirms Jaguar Land Rover’s Win Against Landwind for Copying Evoque	Schwegman, Lundberg & Woessner, P.A.
Jul 14 2021	First Generic Declarations Published on China’s New Patent Linkage System	Schwegman, Lundberg & Woessner, P.A.
Aug 1 2021	China’s Supreme People’s Court Rules Utility Model Patent Unenforceable if Corresponding Invention Patent Application Fails to Grants	Schwegman, Lundberg & Woessner, P.A.
Aug 29 2021	China’s National Intellectual Property Administration Releases Patent Agency Industry Status Report (2020): Chinese Patent Attorneys File 222 Patent Applications Per Year on Average	Schwegman, Lundberg & Woessner, P.A.
Oct 21 2021	China’s Supreme People’s Court Submits Report to the National People’s Congress on Judicial Work on the People’s Courts in Intellectual Property	Schwegman, Lundberg & Woessner, P.A.
Nov 4 2021	China’s Supreme People’s Court Rules Unintentional Short Payment of Annuity Fee Causes Termination of Patent Rights	Schwegman, Lundberg & Woessner, P.A.
Apr 12 2011	PTO Issues Final Rule to Implement Prioritized Examination Track (Track I)	Schwegman, Lundberg & Woessner, P.A.
Sep 15 2011	Myriad Petition For Rehearing Denied	Schwegman, Lundberg & Woessner, P.A.
Jun 12 2015	OIP Technologies Inc., v. Amazon.com, Inc, (Fed. Cir. 2012-1696)	Schwegman, Lundberg & Woessner, P.A.
Dec 4 2017	“An Unusual Case” – Promega Corp. v. Life Technologies Corp.	Schwegman, Lundberg & Woessner, P.A.
Jul 23 2022	China’s National Intellectual Property Administration Releases Guidelines for Intellectual Property Protection at Exhibitions	Schwegman, Lundberg & Woessner, P.A.
Jul 13 2015	In re Cuozzo – Still no changes for the claim interpretation standard during inter partes review proceedings	Schwegman, Lundberg & Woessner, P.A.
Jul 21 2015	PTAB Guidance on its View of Petitioner Estoppel: Westlake Services v. Credit Acceptance Corp	Schwegman, Lundberg & Woessner, P.A.
Sep 23 2022	Reminder: Extended CNIPA Closure for Chinese National Day	Schwegman, Lundberg & Woessner, P.A.
Feb 28 2018	Cleveland Clinic – Time to Purport an Inventive Concept in a Diagnostic Invention?	Schwegman, Lundberg & Woessner, P.A.
Mar 19 2018	In re Urvashi Bhagat – The Slippery Slope of Natural Product Claims	Schwegman, Lundberg & Woessner, P.A.
Mar 26 2018	A Split Panel of the Federal Circuit Reverses PTAB Finding of Unpatentability Without Remand in DSS v. Apple	Schwegman, Lundberg & Woessner, P.A.

Subscribe to The 10 Latest Intellectual Property, Patent, Trademark & Copyright News Articles

Trending News